Innovative Biomarkers For Diagnosis of Diabetes Insipidus And Early Rule Out of Acute Myocardial Infarction
—
filed under:
AMI,
patient management,
Acute Myocardial Infarction,
Troponin,
biomarker,
Acute Coronary Syndrome,
ACS,
arginine vasopressin,
chest pain,
cardiovascular disease,
rule out,
emergency department,
Copeptin,
hyponatremia,
patient monitoring
Assays for the determination of C-terminal pro Arginine Vasopressin (AVP) have shown to be useful in the diagnosis of diabetes insipidus and in the early rule out of acute myocardial infarction. For the reliable measurement of circulating Vasopressin - a key hormone in the human body - Thermo Scientific B·R·A·H·M·S Biomarkers offers three technically different assays.
 |
 |
| |
 |
 |
 |
Final report by NICE Advisory Committee says that “…the B·R·A·H·M·S copeptin assay shows potential to reduce the time taken to rule out myocardial infarction…”
